Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2025   6,962,000      
Beginning balance at Mar. 31, 2025 $ (164,366) $ 70 $ 779,645 $ (942,471) $ (1,610)
Increase (Decrease) in Stockholders' Equity          
Net loss (63,662)     (63,662)  
Foreign currency translation adjustments, net of income taxes 660       660
Change in fair value of convertible note 0        
Shares issued under employee stock incentive plans (in shares)   51,000      
Shares issued under employee stock incentive plans 81   81    
Shares issued related to the SEPA (in shares)   6,320,000      
Shares issued related to the SEPA 66,993 $ 63 66,930    
Stock-based compensation (205)   (205)    
Ending balance (in shares) at Sep. 30, 2025   13,333,000      
Ending balance at Sep. 30, 2025 (160,499) $ 133 846,451 (1,006,133) (950)
Beginning balance (in shares) at Jun. 30, 2025   13,319,000      
Beginning balance at Jun. 30, 2025 (114,386) $ 133 846,046 (959,677) (888)
Increase (Decrease) in Stockholders' Equity          
Net loss (46,456)     (46,456)  
Foreign currency translation adjustments, net of income taxes (62)       (62)
Change in fair value of convertible note 0        
Shares issued under employee stock incentive plans (in shares)   14,000      
Shares issued under employee stock incentive plans 81   81    
Stock-based compensation 324   324    
Ending balance (in shares) at Sep. 30, 2025   13,333,000      
Ending balance at Sep. 30, 2025 $ (160,499) $ 133 846,451 (1,006,133) (950)
Beginning balance (in shares) at Mar. 31, 2026 14,638,000 14,638,000      
Beginning balance at Mar. 31, 2026 $ (198,857) $ 146 853,974 (1,043,517) (9,460)
Increase (Decrease) in Stockholders' Equity          
Net loss (200,143)     (200,143)  
Foreign currency translation adjustments, net of income taxes (230)       (230)
Change in fair value of convertible note 8,444       8,444
Shares issued related to private placement, net (in shares)   10,616,000      
Shares issued related to private placement, net 94,275 $ 106 94,169    
Shares issued under employee stock option plans (in shares)   132,000      
Shares issued under employee stock option plans   $ 1 (1)    
Shares issued under employee stock incentive plans (in shares)   50,000      
Shares issued under employee stock incentive plans 143 $ 1 142    
Shares issued related to the convertible note (in shares)   14,105,000      
Shares issued related to the convertible note 222,571 $ 141 222,430    
Stock-based compensation $ 1,583   1,583    
Ending balance (in shares) at Sep. 30, 2026 39,541,000 39,541,000      
Ending balance at Sep. 30, 2026 $ (72,214) $ 395 1,172,297 (1,243,660) (1,246)
Beginning balance (in shares) at Jun. 30, 2026   39,375,000      
Beginning balance at Jun. 30, 2026 (27,825) $ 393 1,171,684 (1,198,810) (1,092)
Increase (Decrease) in Stockholders' Equity          
Net loss (44,850)     (44,850)  
Foreign currency translation adjustments, net of income taxes (154)       (154)
Change in fair value of convertible note 0        
Shares issued related to private placement, net (363)   (363)    
Shares issued under employee stock option plans (in shares)   132,000      
Shares issued under employee stock option plans   $ 1 (1)    
Shares issued under employee stock incentive plans (in shares)   34,000      
Shares issued under employee stock incentive plans 143 $ 1 142    
Stock-based compensation $ 835   835    
Ending balance (in shares) at Sep. 30, 2026 39,541,000 39,541,000      
Ending balance at Sep. 30, 2026 $ (72,214) $ 395 $ 1,172,297 $ (1,243,660) $ (1,246)